Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 98.19%-995 | -166.26%-71.72K | -6,888.63%-315.82K | -153.99%-199.53K | 20.54%-113.03K | -55.04K | -128.99%-26.94K | 84.53%-4.52K | 49.66%-78.56K | -197.29%-142.25K |
| Net income from continuing operations | 14.99%-13.92K | -325.96%-142.65K | -1,309.15%-162.28K | -10.91%-206.56K | 12.92%-145.18K | ---16.37K | ---33.49K | 40.98%-11.52K | -254.17%-186.24K | -4,276.06%-166.73K |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --98K | --0 |
| Change In working capital | 133.43%12.92K | 982.61%70.92K | -2,294.34%-153.54K | -27.35%7.04K | 31.34%32.15K | ---38.66K | 228.80%6.55K | 172.07%7K | 115.26%9.68K | 705.87%24.48K |
| -Change in receivables | 495.37%18.28K | 30.09%-1.51K | -1,693.21%-9.77K | -128.34%-3.37K | -113.99%-3.73K | --3.07K | 84.39%-2.16K | 43.11%-545 | 176.62%11.88K | 366.04%26.68K |
| -Change in prepaid assets | --17.14K | --41.11K | ---98.81K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in payables and accrued expense | 46.10%-22.49K | 259.57%31.32K | -696.08%-44.96K | 572.65%10.4K | 1,730.26%35.88K | ---41.73K | -0.45%8.71K | 186.19%7.54K | 95.41%-2.2K | -151.93%-2.2K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 98.19%-995 | -166.26%-71.72K | -6,888.63%-315.82K | -153.99%-199.53K | -49.02%-113.03K | ---55.04K | -201.58%-26.94K | 84.53%-4.52K | 49.66%-78.56K | -58.52%-75.85K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | -1,503.47%-160.35K | -276.74K | -266.74K | 0 | 0 | -10K | 0 | 0 |
| Net PPE purchase and sale | --0 | --0 | -1,535.66%-163.57K | ---229.51K | ---219.51K | --0 | --0 | ---10K | --0 | --0 |
| Net business purchase and sale | --0 | --0 | --3.22K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---47.23K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | -1,503.47%-160.35K | ---276.74K | ---266.74K | --0 | --0 | ---10K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 51,682.94%867.88K | 702.93K | 164.95K | -99.67%1.68K | 0 | ||||
| Net common stock issuance | --0 | ---- | ---- | --882.5K | 42,913.25%717.55K | --164.95K | ---- | ---- | --0 | ---1.68K |
| Net other financing activities | ---- | ---- | ---- | -972.20%-14.62K | ---- | ---- | ---- | ---- | 101.16%1.68K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | ---- | ---- | 51,682.94%867.88K | --702.93K | --164.95K | ---- | ---- | -99.67%1.68K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -63.43%43.49K | -22.17%113.5K | 244.22%551.97K | -32.41%160.35K | 34.18%228.81K | -30.28%118.9K | -30.45%145.83K | -32.41%160.35K | 81.99%237.23K | -65.33%170.53K |
| Current changes in cash | -100.91%-995 | -166.26%-71.72K | -3,179.59%-476.16K | 609.38%391.61K | 3,276.59%323.15K | --109.92K | 31.22%-26.94K | 47.29%-14.52K | -171.93%-76.88K | 96.00%-10.17K |
| Effect of exchange rate changes | ---- | --1.71K | --37.7K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| End cash Position | -81.43%42.49K | -63.43%43.49K | -22.17%113.5K | 244.22%551.97K | 244.22%551.97K | 34.18%228.81K | -30.28%118.9K | -30.45%145.83K | -32.41%160.35K | -32.41%160.35K |
| Free cash from | 98.19%-995 | -166.26%-71.72K | -3,201.76%-479.38K | -446.14%-429.04K | -338.40%-332.54K | ---55.04K | -201.58%-26.94K | 50.31%-14.52K | 55.38%-78.56K | -11.80%-75.85K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.